This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Wistar Institute. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of David E. Jensen
Introduction
David E. Jensen is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on the BRCA1 associated polynucleotide (BAP-1), which has important implications for cancer diagnostics and therapeutics.
Latest Patents
David E. Jensen holds a patent for the invention titled "BRCA1 associated polynucleotide (BAP-1) and uses therefor." This patent includes nucleic acid and amino acid sequences of a BRCA1 associated protein, BAP-1. These sequences, along with the protein and anti-BAP-1 antibodies, are useful in therapeutics and diagnostics for cancers associated with loss of the 3p21 chromosomal region and/or inappropriate BAP-1 levels. He has 1 patent to his name.
Career Highlights
David E. Jensen is affiliated with The Wistar Institute, where he conducts his research. His work has been instrumental in advancing the understanding of cancer biology and developing potential therapeutic strategies.
Collaborations
One of his notable collaborators is Frank J. Rauscher, III. Their partnership has contributed to the advancement of research in the field of cancer.
Conclusion
David E. Jensen's innovative work in cancer research highlights the importance of scientific advancements in improving diagnostics and therapeutics. His contributions continue to impact the field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile